Consolidated Statements of Shareholders' Equity Statement - USD ($) $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit	Non-Controlling Interest
Beginning Balance (in shares) at Dec. 31, 2021		53,367,136
Beginning Balance at Dec. 31, 2021	$ 40,221	$ 475,644	$ (468)	$ (434,955)	$ 0
Stock issued under employee equity incentive plans (in shares)		630,876
Stock issued under employee equity incentive plans	217	$ 217
Stock-based compensation expense	1,049	$ 1,049
Foreign currency translation adjustment	(152)		(152)
Less: Net (income) loss attributable to redeemable non-controlling interest	470
Net income (loss)	(4,592)			(4,592)
Ending Balance (in shares) at Mar. 31, 2022		53,998,012
Ending Balance at Mar. 31, 2022	36,743	$ 476,910	(620)	(439,547)	0
Beginning Balance (in shares) at Dec. 31, 2022		55,113,186
Beginning Balance at Dec. 31, 2022	43,331	$ 481,229	2,178	(450,985)	10,909
Stock issued under employee equity incentive plans (in shares)		606,539
Stock issued under employee equity incentive plans	156	$ 156
Stock-based compensation expense	1,166	$ 1,166
Foreign currency translation adjustment	(366)		(333)		(33)
Net proceeds from issuance of equity interest to non-controlling interest	14,596				14,596
Less: Net (income) loss attributable to redeemable non-controlling interest	(338)				(338)
Net income (loss)	(9,396)			(9,396)
Ending Balance (in shares) at Mar. 31, 2023		55,719,725
Ending Balance at Mar. 31, 2023	$ 49,149	$ 482,551	$ 1,845	$ (460,381)	$ 25,134